Aripiprazole in the Treatment of Tourette's Syndrome
Status:
Terminated
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, flexible dose study designed to evaluate the safety and efficacy of
aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms
and with or without ADHD symptoms.